ANO1 and lung cancer: As shown in Fig 4A and 4B, transfecting GLC82 lung cancer cells with ANO1 shRNA inhibited the wound filling about 66.8% at 24 h, 67.5% at 48 h and 74.3% at 72 h, as compared with scrambled shRNA.